Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

Presentation TCT 2016

Strategies to Reduce the Frequency of New Pacemakers After TAVR: Imaging, Procedural, and Device-Related Factors

Presenter: Neil E. Moat, John G. Webb, Ian T. Meredith

October 31, 2016

Presentation TCT 2016

Complications 4. Conduction Disturbances: Clinical Implications of New LBBB and New Pacemakers After TAVR

Presenter: Neil E. Moat, John G. Webb, Marina Urena

October 31, 2016

Presentation TCT 2016

Pacemaker-Based Treatment for Hypertension (Backbeat)

Presenter: Darren Sherman

October 31, 2016

Presentation TCT 2016

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing

Presenter: Bernard J. Gersh, Harry Rakowski, Michael A. Fifer

October 30, 2016

Presentation TCT 2016

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro ICD!

Presenter: Bernard J. Gersh, Harry Rakowski, George S. Hanzel

October 30, 2016

Presentation TVT 2016

Clinical Implications of New LBBB and New Pacemakers After TAVR

Presenter: Azeem Latib

June 16, 2016

Presentation

Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With Sapien 3

Presenter: Oliver Husser

February 04, 2016

Presentation TCT 2015

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Presenter: Isaac George, Augusto D. Pichard, Susheel Kodali

October 15, 2015

Presentation TCT 2015

Risk of Paradoxical Embolism With Pacemaker Leads

Presenter: John D. Carroll, Mark Reisman, Samir R. Kapadia

October 14, 2015

Presentation TCT 2015

How to Prevent Annular Rupture, Coronary Occlusion, and Permanent Pacemakers

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Oscar A. Mendiz

October 11, 2015

Presentation TCT 2015

Predictors and Clinical Outcomes of Permanent Pacemaker Implantation After TAVR

Presenter: Marian C. Hawkey, Ganesh Manoharan

October 11, 2015

Presentation TVT 2015

Thoughtful Commentary: High Risk for Pacemaker With LV Dysfunction and TAVR

Presenter: Antonio Colombo, A. Pieter Kappetein, Tamim Nazif

June 05, 2015

Presentation TVT 2015

Case Presentation: High Risk for Pacemaker With LV Dysfunction and TAVR

Presenter: Antonio Colombo, A. Pieter Kappetein, Hemal Gada

June 05, 2015

Presentation

Chronic Performance of a Leadless Cardiac Pacemaker: 1-Year Follow-up of the LEADLESS Trial

Presenter: Reinoud E. Knops

April 14, 2015

Presentation

PARTNER: Predictors and Clinical Outcomes of Permanent Pacemaker Implantation After TAVR

Presenter: T.M. Nazif

January 19, 2015

Presentation

Unraveling the (Arte)fact of Increased Pacemaker Rate With the Edwards Sapien 3 Valve

Presenter: 92178|Giuseppe Tarantini

November 25, 2014

Presentation TCT 2014

TCT 63: Objective Assessment of Intracardiac Conduction to Guide Permanent Pacemaker Implantation Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Presenter: Igor F. Palacios, Augusto D. Pichard, Kishore J. Harjai, Malek Al-Hawwas, MD

September 16, 2014

Presentation TCT 2014

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Tamim Nazif

September 14, 2014

Presentation

Predictors of Permanent Pacemaker in Patients with Severe Aortic Stenosis Undergoing TAVR

Presenter: G.C.M. Siontis

July 08, 2014

Presentation TVT 2014

New LBBB and Permanent Pacemakers Arent Detrimental in this AS Population

Presenter: Nicolo Piazza

June 07, 2014

Advertisement

Strategies to Reduce the Frequency of New Pacemakers After TAVR: Imaging, Procedural, and Device-Related Factors

Complications 4. Conduction Disturbances: Clinical Implications of New LBBB and New Pacemakers After TAVR

Pacemaker-Based Treatment for Hypertension (Backbeat)

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro ICD!

Clinical Implications of New LBBB and New Pacemakers After TAVR

Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With Sapien 3

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Risk of Paradoxical Embolism With Pacemaker Leads

How to Prevent Annular Rupture, Coronary Occlusion, and Permanent Pacemakers

Predictors and Clinical Outcomes of Permanent Pacemaker Implantation After TAVR

Thoughtful Commentary: High Risk for Pacemaker With LV Dysfunction and TAVR

Case Presentation: High Risk for Pacemaker With LV Dysfunction and TAVR

Chronic Performance of a Leadless Cardiac Pacemaker: 1-Year Follow-up of the LEADLESS Trial

PARTNER: Predictors and Clinical Outcomes of Permanent Pacemaker Implantation After TAVR

Unraveling the (Arte)fact of Increased Pacemaker Rate With the Edwards Sapien 3 Valve

TCT 63: Objective Assessment of Intracardiac Conduction to Guide Permanent Pacemaker Implantation Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Predictors of Permanent Pacemaker in Patients with Severe Aortic Stenosis Undergoing TAVR

New LBBB and Permanent Pacemakers Arent Detrimental in this AS Population

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content